NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/06/2026
Back to search
Official data from USPTO
MEDEXUS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
04/07/2026
Trademark type
Combined
Nice classes
5
Filing date
08/30/2018
Registration date
01/12/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/06/2026
Last transaction
04/07/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/10/2014
First use in commerce
11/22/2019
Drawing code
3
Owner type
03
Owner location
Bolton, Ontario, CA
Examiner
PRATER, JILL I
Current location
Historical data usage
Mark description
The mark consists of the word "MEDEXUS" stacked on top, and slightly to the left of, the word "PHARMA". To the left of the word "PHARMA", and below the letters "ME" in "MEDEXUS", is a square that has a line cutting through the lower portion of the square and continuing to underline the word "PHARMA".
Holders and representatives
Holders
Medexus Inc.
Representatives
William Zac Duffy Munsch Hardt Kopf & Harr, PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical preparations for the treatment of arthritisauto-immune diseasescancer
Publications
History of USPTO decisions and trademark events.
43 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/06/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/06/2026
E815
TEAS SECTION 8 & 15 RECEIVED
01/12/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/12/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/03/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/05/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/04/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/23/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/22/2020
EX2G
SOU EXTENSION 2 GRANTED
10/22/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/22/2020
IUAF
USE AMENDMENT FILED
10/14/2020
EXT2
SOU EXTENSION 2 FILED
10/14/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/14/2020
EISU
TEAS STATEMENT OF USE RECEIVED
10/14/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/13/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/24/2020
EX1G
SOU EXTENSION 1 GRANTED
04/22/2020
EXT1
SOU EXTENSION 1 FILED
04/22/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/22/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/22/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/27/2019
PUBO
PUBLISHED FOR OPPOSITION
08/27/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/10/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/13/2018
GNRT
NON-FINAL ACTION E-MAILED
12/13/2018
CNRT
NON-FINAL ACTION WRITTEN
12/13/2018
DOCK
ASSIGNED TO EXAMINER
12/13/2018
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/07/2018
ALIE
ASSIGNED TO LIE
11/05/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/25/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2018
NWAP
NEW APPLICATION ENTERED
09/03/2018
Continuous trademark protection
Get notified about every new filing that threatens MEDEXUS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.